The CHEK2 c.1100delC mutation plays an irrelevant role in breast cancer predisposition in Italy
Authors:
- 27 May 2004
- journal article
- letter
- Published by Hindawi Limited in Human Mutation
- Vol. 24 (1) , 100-101
Abstract
Click on the article title to read more.Keywords
This publication has 7 references indexed in Scilit:
- Breast and Ovarian CancerNew England Journal of Medicine, 2003
- The CHEK2 1100delC Mutation Identifies Families with a Hereditary Breast and Colorectal Cancer PhenotypeThe American Journal of Human Genetics, 2003
- Variants in CHEK2 Other than 1100delC Do Not Make a Major Contribution to Breast Cancer SusceptibilityThe American Journal of Human Genetics, 2003
- Mutations in CHEK2 Associated with Prostate Cancer RiskThe American Journal of Human Genetics, 2003
- Frequency of CHEK2*1100delC in New York breast cancer cases and controlsBMC Medical Genetics, 2003
- A CHEK2 Genetic Variant Contributing to a Substantial Fraction of Familial Breast CancerThe American Journal of Human Genetics, 2002
- Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutationsNature Genetics, 2002